Neogen Chemicals Ltd

The company's financial performance has deteriorated significantly in recent years. While historical sales growth was strong, it has recently stagnated, posting only 0.65% growth in the latest year. More alarmingly, profit growth has turned sharply negative. The compounded profit growth over the last 3 and 5 years is negative, culminating in a -28.66% decline in the latest year. This indicates a severe contraction in profitability. Operating margins have also been on a downtrend, falling from 19% in 2021 to 16% in 2024. Quarterly results show high volatility in both sales and profits, pointing to instability in core operations. The recent performance reflects a significant weakness in maintaining growth and profitability.

The company's ability to generate returns from its capital has worsened dramatically. The Return on Capital Employed (ROCE) has been in a consistent and steep decline, falling from a healthy 26% in 2019 to a mere 9% in 2024. This indicates that the new capital being deployed, likely for expansion, is generating progressively lower returns. Similarly, the Return on Equity (ROE) has collapsed, with the last year's ROE at just 4%, a very poor return for shareholders. The Cash Conversion Cycle (CCC) has also expanded drastically from 169 days in 2019 to an alarming 376 days in 2024. This massive increase in CCC points to severe inefficiencies in managing inventory and collecting receivables, tying up significant cash in working capital.

The company's financial health is under pressure due to rising debt and weakening coverage ratios. Total borrowings have increased substantially over the past few years, rising from 137 Cr in 2020 to 409 Cr in 2024. While the Debt-to-Equity ratio at 0.54 is not yet at a critical level, the rapid increase in absolute debt is a concern, especially when profits are falling. This has led to a sharp increase in interest expenses, which grew from 12 Cr in 2020 to 42 Cr in 2024. Consequently, the Interest Coverage Ratio has weakened from 4.83x in 2020 to just 2.62x in 2024, reducing the company's buffer to service its debt. Consistent dividend payout is a minor positive but is overshadowed by these growing financial risks.

The ownership structure presents a mixed picture. A significant concern is the continuous dilution of promoter holding, which has decreased from 70.01% in March 2020 to 56.89% in March 2024. This consistent selling by the promoters could be perceived as a lack of confidence in the company's future prospects. On the other hand, the company has seen a steady increase in institutional ownership during the same period. DII holding increased from 17.13% to 22.14%, and FII holding rose from 0.55% to 4.56%. This growing interest from institutional investors provides a counterbalance to the declining promoter stake, suggesting that some professional investors see long-term value despite the current challenges. The overall assessment is average due to these conflicting signals.

A significant red flag is the major divergence between reported profit and cash flow generation. In FY 2024, the company reported a Net Profit of 36 Cr but had a negative Cash Flow from Operations of -29 Cr. This discrepancy is largely driven by a massive increase in working capital, with Debtor Days and Inventory Days rising to 149 and 365, respectively. The Cash Conversion Cycle has consequently exploded to 376 days. This indicates that profits are not being converted into cash, and a large amount of capital is stuck in inventory and receivables. This situation points to potential issues with inventory management, credit policies, or aggressive revenue recognition.

The company faces significant interest rate risk due to its rising debt levels and declining profitability. Total borrowings have tripled from 137 Cr in 2020 to 409 Cr in 2024, leading to a corresponding surge in interest payments from 12 Cr to 42 Cr over the same period. The Interest Coverage Ratio has deteriorated from a comfortable 4.83x in 2020 to a weak 2.62x in 2024. This low and declining ratio indicates a reduced capacity to service its debt obligations from operating profits, making the company highly vulnerable to any increase in interest rates or a further dip in operational performance.